AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

HPV DNA subtype is prognostic factor in early stage disease.

Women's Health Weekly

| September 02, 2004 | COPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 SEP 2 - (NewsRx.com & NewsRx.net) -- Gynecologic oncologists in Sweden have determined that the subtype of human papillomavirus (HPV) present in cervical cancer tumors is a prognostic factor in early-stage cervical cancer.

M. Graflund and colleagues, Orebro University Hospital, examined "the relation between the expression of p53, bcl-2, p21(WAF1), MIB-1, HER-2/neu, DNA ploidy, and HPV16 or 18 infections with clinical parameters."

"HPV-DNA was evaluated in 171 early cervical carcinomas treated from 1965 to 1990 and detected by polymerase chain reaction on paraffin specimens obtained before therapy was started," the researchers said.

They found HPV DNA in 86 of 110 tumors (78%). By subtype, HPV16 was detected 62 of the 110 tumors (56%), HPV18 in 9 tumors (8%), and HPV35 in 23 tumors (21%).

Graflund and coworkers reported, "Patients with HPV16 or 18 were significantly (p=.011) younger than patients with tumors not containing these two HPV subtypes. Lymph node metastases were seen more frequently (p=.047) in tumors expressing HPV16 or 18. Tumor size was associated with the HPV-type.

"The frequency of DNA aneuploidy was lower in high-risk HPV tumors than in tumors with other HPV subtypes (p=.014). MIB-1 expression was highly significantly (p=.00007) associated with presence of HPV 16 or 18," they continued.

Their analysis also showed a ...

Related articles from newspapers, magazines, journals, and more
Digene Recognizes Women's Health Advocates For Focus on Cervical Cancer...
Press release article from: PR Newswire October 2, 2003 700+ words
...that incorporate HPV DNA testing in routine cervical cancer screening. The...important role of HPV DNA testing in cervical cancer screening. We also...include high-risk HPV DNA testing in primary cervical cancer screening for women...
Spanish Medical Societies Issue First European National Consensus Guidelines...
Press release article from: PR Newswire December 14, 2006 700+ words
...national consensus cervical cancer prevention guidelines that recommend HPV DNA testing for routine...the cause of cervical cancer, that is clinically...recommend use of the HPV DNA test in conjunction...Digene's hc2 HPV DNA Test uses advanced...HPV. ...
CDC Recognizes HPV DNA Testing For Cervical Cancer Screening.
Press release article from: PR Newswire December 11, 2006 700+ words
...potential benefit of HPV DNA testing for cervical cancer screening in a new...be used to detect HPV DNA. The only such test...reinforce the value of HPV DNA testing in the frontline...efforts to eliminate cervical cancer, and thus bring...
Digene Signs Three-Year Agreement With Quest Diagnostics to Provide Physicians...
Press release article from: PR Newswire January 27, 2004 700+ words
...high-risk HPV DNA testing for routine cervical cancer screening in...to include HPV DNA testing as part of routine cervical cancer screening for...than 99% of cervical cancer cases. The...High-Risk HPV DNA Test(TM...
EUROGIN 2003 Conference Reinforces Role of HPV DNA Testing in Cervical Cancer...
Press release article from: PR Newswire April 17, 2003 700+ words
...testing in primary cervical cancer screening programs...High-Risk (HR) HPV DNA Test with a Pap...greater than 99% of cervical cancer cases. The Digene hc2 HR HPV DNA Test is approved...primary screen for cervical cancer and its precursors...
HPV DNA Testing and HPV Vaccines Described by Experts as Combination That...
Press release article from: PR Newswire April 27, 2006 700+ words
...standard of care for cervical cancer screening, as...The use of HPV DNA testing in primary cervical cancer screening is increasing...develop, stopping cervical cancer in its tracks...hc2 High-Risk HPV DNA Test(R) is the...
Digene signs three-year agreement with Quest Diagnostics to provide physicians...
News wire article from: Asia Africa Intelligence Wire January 27, 2004 700+ words
...will offer its physician clients high-risk HPV DNA testing for routine cervical cancer screening in women 30 years of age and older...test was approved in Mar 2003 for primary cervical cancer screening, in conjunction with a Pap test...
HPV DNA Testing Likely to Become Primary Cervical Cancer Screening Tool as...
Press release article from: PR Newswire September 11, 2006 700+ words
...benefit of widespread use of HPV DNA testing cited by the experts...virus are present. "HPV DNA testing could provide...Wright. Worldwide, cervical cancer affects more than 400...company's hc2 High-Risk HPV DNA Test(R) is the only...
Digene Announces Contract with U.S. Army for Its Hybrid Capture(R) 2 HPV DNA...
Press release article from: PR Newswire April 3, 2002 700+ words
...R) 2 (HC2) HPV DNA Test, in its worldwide cervical cancer screening program...protection against cervical cancer, but can also...Hybrid Capture 2 HPV DNA Test. The Army...greater than 99% of cervical cancer cases. The Digene...
Digene's HPV DNA Test Now Offered by Columbia University To Better Protect...
Press release article from: PR Newswire February 19, 2004 700+ words
...the presence of cervical cancer or its precursor...the Pap, the HPV DNA test has been...99 percent of cervical cancer cases. Digene's high-risk HPV DNA test is approved...1) Routine cervical cancer screening in women...
For more facts and information, see all results

Source: HighBeam Research, HPV DNA subtype is prognostic factor in early stage disease.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA